Chem. J. Chinese Universities ›› 2017, Vol. 38 ›› Issue (9): 1590.doi: 10.7503/cjcu20170136

• Organic Chemistry • Previous Articles     Next Articles

Synthesis and Biological Activity of Novel PI3K/mTOR Inhibitors

WANG Lei1,2, ZHENG Guojun1,*(), JI Qi2,*(), CHEN Bo2, GONG Longlong2, GAO Congmin2, DU Zhenjian2, ZHANG Xingmin2   

  1. 1. Beijing University of Chemical Technology, College of Life Science and Technology, Beijing 100029, China
    2. ForelandPharma Co. Ltd, Beijing 101111, China
  • Received:2017-03-07 Online:2017-09-10 Published:2017-07-21
  • Contact: ZHENG Guojun,JI Qi E-mail:zhenggj@mail.buct.edu.cn;qi.ji@forelandpharma.com

Abstract:

A series of new phosphatidylinositol 3-kinase/mammalian target of rapamycin(PI3K/mTOR) inhibitors with optimized synthetic process was designed and synthesized, the correctness of the structure was determined by 1H NMR and LC-MS and the antitumor activities of these compounds were evaluated in 3 tumor celllines by MTT colorimetric method. Compound 11 showed very strong inhibition of MV4-11 cell growth, and was selected as a leading compound for further development of anti-leukemia drug candidate.

Key words: Phosphatidylinositol 3-kinase/mammalian target of rapamycin(PI3K/mTOR) inhibitor, Antitumor viability, Structure-activity relationship

CLC Number: 

TrendMD: